Brief: Sonnet Biotherapeutics - On March 23, Received Notice Of Delisting Or Failure To Satisfy Continued Listing Rule Or Standard From Nasdaq

Sonnet Biotherapeutics Holdings

24/03/2023 20:43

March 24 (Reuters) - Sonnet Biotherapeutics Holdings Inc
 SONN.O :
    * SONNET BIOTHERAPEUTICS -  ON MARCH 23, RECEIVED NOTICE OF
DELISTING OR FAILURE TO SATISFY A CONTINUED LISTING RULE OR
STANDARD FROM NASDAQ


Further company coverage:  SONN.O 

 ((Reuters.Briefs@thomsonreuters.com;))